BRUNO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 13.911
EU - Europa 1.657
AS - Asia 1.307
SA - Sud America 214
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 17.121
Nazione #
US - Stati Uniti d'America 13.873
SG - Singapore 654
DE - Germania 601
CN - Cina 338
UA - Ucraina 199
IT - Italia 190
BR - Brasile 180
IE - Irlanda 155
RU - Federazione Russa 139
GB - Regno Unito 122
HK - Hong Kong 117
SE - Svezia 77
VN - Vietnam 53
FI - Finlandia 51
KR - Corea 42
FR - Francia 40
NL - Olanda 24
CA - Canada 23
JP - Giappone 17
ZA - Sudafrica 17
IN - India 15
AR - Argentina 14
BE - Belgio 14
PL - Polonia 12
UZ - Uzbekistan 12
BD - Bangladesh 11
MX - Messico 10
TR - Turchia 9
CZ - Repubblica Ceca 8
ID - Indonesia 8
AT - Austria 6
SA - Arabia Saudita 6
CO - Colombia 5
PY - Paraguay 5
EC - Ecuador 4
ES - Italia 4
IQ - Iraq 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
IR - Iran 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
KG - Kirghizistan 2
PE - Perù 2
PH - Filippine 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 17.121
Città #
Woodbridge 4.157
Wilmington 3.250
Houston 2.873
Ann Arbor 450
Chandler 443
Singapore 368
Fairfield 354
Ashburn 236
Dallas 187
Jacksonville 178
Beijing 164
Dublin 153
Seattle 118
Hong Kong 117
Dearborn 115
New York 112
Cambridge 110
Medford 109
The Dalles 101
Santa Clara 76
Rome 68
Zhengzhou 53
Los Angeles 51
Lawrence 50
Munich 49
Buffalo 27
Ho Chi Minh City 24
Council Bluffs 22
São Paulo 21
San Diego 19
Brooklyn 16
Moscow 16
Hefei 15
London 15
Brussels 14
Chicago 14
Mülheim 14
Hanoi 13
Johannesburg 13
Milan 13
Nanjing 12
Tokyo 12
Columbus 11
Norwalk 11
Palo Alto 11
University Park 11
Boardman 10
Boston 10
Menlo Park 9
Montreal 9
San Francisco 9
Shanghai 9
Warsaw 9
Brno 8
Orem 8
Amsterdam 7
Colorado Springs 7
Creede 7
Denver 7
Mountain View 7
Nuremberg 7
Rio de Janeiro 7
San Jose 7
Ankara 6
Center 6
Chennai 6
Guangzhou 6
Kunming 6
Manchester 6
Mexico City 6
Nürnberg 6
Redondo Beach 6
Stockholm 6
Turku 6
Burago di Molgora 5
Redwood City 5
Seoul 5
Verona 5
Belo Horizonte 4
Falls Church 4
Hebei 4
Helsinki 4
Hounslow 4
Inverigo 4
Jakarta 4
Mumbai 4
Nanchang 4
Paris 4
Poplar 4
Riyadh 4
Toronto 4
Arosio 3
Brasília 3
Campinas 3
Detroit 3
Frankfurt am Main 3
Indiana 3
Jinan 3
Juiz de Fora 3
Jundiaí 3
Totale 14.568
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 511
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 490
CD7 expression in acute myeloid leukemia 479
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 479
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 478
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 477
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 474
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 457
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 454
Diagnosis of acute myeloid leukemia and system Coulter VCS 452
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 451
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 448
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 444
Biological features of acute myeloid leukemia in the elderly 444
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 443
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 436
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 432
AML-M0: a biological and clinical profile 428
Biological pattern of AML-M0 versus AML-M1: Response 421
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 416
Evaluation of biological features of cord blood units collected with different methods after cesarean section 414
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 411
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 411
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 406
P-glycoprotein expression in de novo acute myeloid leukemia 405
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 402
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 397
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 391
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 387
Lineage identification of acute leukemias: relevance of immunological and ultrastruttural techniques 374
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 357
Apoptosis and immaturity in acute myeloid leukemia 335
Prognostic value of cell marker analysis in de-novo acute myeloid-leukemia 335
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 334
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 332
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia 330
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 322
Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 173
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 133
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 130
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 126
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 122
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 121
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 118
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation 116
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 105
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 95
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 94
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab 75
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 66
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 64
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 59
Osteopontin Is Associated with Multiple Sclerosis Relapses 58
Theoretical and therapeutic implications of the spasticity-plus syndrome model in multiple sclerosis 55
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 53
Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery? 35
Totale 17.255
Categoria #
all - tutte 41.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021942 0 0 0 0 0 187 349 198 72 30 87 19
2021/2022579 15 57 5 48 10 85 24 24 50 59 31 171
2022/2023947 91 84 85 114 68 212 81 47 92 15 39 19
2023/2024312 44 7 12 2 31 117 10 1 2 3 24 59
2024/20251.280 42 345 175 55 32 52 73 68 115 128 113 82
2025/20261.234 249 110 398 199 181 97 0 0 0 0 0 0
Totale 17.255